OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002312$10.0858

Sichuan Development Lomon Co Ltd

Commodity ChemicalsVerified

Sichuan Development Lomon Co Ltd has a market capitalization of CNY 19.03 billion and a price-to-earnings ratio of 45.96, indicating a relatively high valuation compared to earnings. The company's price-to-book ratio of 1.98 suggests that the market values the company at nearly twice its book value, which may reflect expectations of future growth or intangible assets. However, the company's free cash flow is negative at CNY -160.5 million, and capital expenditures are substantial at CNY -752.3 million, indicating ongoing investment in operations. Profitability metrics show a return on equity of 4.31% and a return on assets of 2.06%, both of which are below the typical thresholds for high-performing chemical firms. The company's operating margin is 5.81% (CNY 578.7 million operating income on CNY 9.96 billion revenue), and its net margin is 4.16% (CNY 414.0 million net income on CNY 9.96 billion revenue). These figures suggest that the company is generating modest returns relative to its asset base and revenue. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic conditions and regulatory changes in China. The company's debt-to-equity ratio of 0.74 indicates a moderate level of leverage, and its current ratio of 1.2 suggests that it has sufficient short-term assets to cover its short-term liabilities, though with limited buffer. Looking ahead, the company is expected to grow revenue by 98.6% in the current fiscal year, based on analyst estimates of CNY 0.43 per share compared to the actual CNY 0.22 per share. However, the high price-to-earnings ratio and negative free cash flow raise concerns about the sustainability of this growth. The company's capital expenditures are expected to remain high, which could further strain liquidity if not offset by revenue growth. The company faces moderate liquidity risk due to its negative net cash position after subtracting total debt. While dilution risk is currently low, the company's reliance on debt financing and capital expenditures could increase the need for future equity or debt offerings, potentially leading to dilution. Recent filings and transcripts do not indicate any major strategic shifts or new product launches, suggesting that the company is maintaining its current business model.

30-day price · 002312-1.61 (-14.2%)
Low$9.72High$11.76Close$9.73As of22 May, 00:00 UTC
Profile
CompanySichuan Development Lomon Co Ltd
Ticker002312.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Sichuan Development Lomon Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily serving industrial and consumer markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Sichuan Development Lomon Co Ltd has a market capitalization of CNY 19.03 billion and a price-to-earnings ratio of 45.96, indicating a relatively high valuation compared to earnings. The company's price-to-book ratio of 1.98 suggests that the market values the company at nearly twice its book value, which may reflect expectations of future growth or intangible assets. However, the company's free cash flow is negative at CNY -160.5 million, and capital expenditures are substantial at CNY -752.3 million, indicating ongoing investment in operations. Profitability metrics show a return on equity of 4.31% and a return on assets of 2.06%, both of which are below the typical thresholds for high-performing chemical firms. The company's operating margin is 5.81% (CNY 578.7 million operating income on CNY 9.96 billion revenue), and its net margin is 4.16% (CNY 414.0 million net income on CNY 9.96 billion revenue). These figures suggest that the company is generating modest returns relative to its asset base and revenue. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic conditions and regulatory changes in China. The company's debt-to-equity ratio of 0.74 indicates a moderate level of leverage, and its current ratio of 1.2 suggests that it has sufficient short-term assets to cover its short-term liabilities, though with limited buffer. Looking ahead, the company is expected to grow revenue by 98.6% in the current fiscal year, based on analyst estimates of CNY 0.43 per share compared to the actual CNY 0.22 per share. However, the high price-to-earnings ratio and negative free cash flow raise concerns about the sustainability of this growth. The company's capital expenditures are expected to remain high, which could further strain liquidity if not offset by revenue growth. The company faces moderate liquidity risk due to its negative net cash position after subtracting total debt. While dilution risk is currently low, the company's reliance on debt financing and capital expenditures could increase the need for future equity or debt offerings, potentially leading to dilution. Recent filings and transcripts do not indicate any major strategic shifts or new product launches, suggesting that the company is maintaining its current business model.
Key takeaways
  • The company is valued at a high price-to-earnings ratio of 45.96, suggesting market optimism about future earnings potential.
  • Return on equity and return on assets are below industry benchmarks, indicating modest profitability.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional and sector-specific risks.
  • Analysts expect strong earnings growth, but the company's negative free cash flow and high capital expenditures may limit its ability to sustain this growth.
  • Liquidity risk is moderate, and dilution risk is currently low, but could increase if the company requires additional financing.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$9.96B
Gross profit$1.28B
Operating income$578.7M
Net income$414.0M
R&D
SG&A
D&A
SBC
Operating cash flow$514.6M
CapEx-$752.3M
Free cash flow-$160.5M
Total assets$20.13B
Total liabilities$10.51B
Total equity$9.61B
Cash & equivalents
Long-term debt$7.14B
Valuation
Market price$10.08
Market cap$19.03B
Enterprise value$26.16B
P/E46.0
Reported non-GAAP P/E
EV/Revenue2.6
EV/Op income45.2
EV/OCF50.9
P/B2.0
P/Tangible book2.0
Tangible book$9.61B
Net cash-$7.14B
Current ratio1.2
Debt/Equity0.7
ROA2.1%
ROE4.3%
Cash conversion1.2%
CapEx/Revenue-7.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002312Activity
Op margin5.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin12.9%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity74.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.43 CNY
Last actual EPS0.22 CNY
Mean revenue estimate10,355,000,000 CNY
Last actual revenue9,956,355,000 CNY
Mean EBIT estimate1,028,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:01 UTCJob: e1cfda34